Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Luigi

Naldi

,

MD

Consultant Dermatologist
San Raffaele Hospital
Milan
,
Italy
Councilor Since: March 1, 2012
IPC Councilor
Dr. Luigi Naldi earned a diploma in Classical Studies and a degree in Industrial Design from the Scuola Politecnica di Design in Milan before transitioning to medicine. He graduated as a medical doctor from the University of Pavia in 1981.

From 1984 to 1986, he worked as a junior investigator at the Laboratory of Clinical Pharmacology at the Mario Negri Institute in Milan. In 1988, he moved into clinical practice at the Department of Dermatology, University of Milan, based at Bergamo General Hospital. He qualified as a Full Professor of Dermatology in 2013.

From 2017 to 2024, he held the position of Director of the Department of Dermatology at the General Hospital of Vicenza. He is currently a consultant at San Raffaele Hospital in Milan.

Dr. Naldi has always regarded the clinical setting as the natural laboratory for clinical research. He is a co-founder of the European Dermatoepidemiology Network (EDEN). From 2003 to 2024, he served as Director of Centro Studi GISED, an independent research centre dedicated to promoting integrated clinical research programs in Dermatology.
Last Updated:
06/26/2025

Areas of Interest

The main research area is in clinical epidemiology of major skin disorders and in the evaluation of complex interventions and educational programs at the population level.

Languages Spoken

English, Italian

Involvement with Other Organization(s)

Advisor to the Italian patient association ADIPSO; expert for the European Medicines Agency (EMA); member of the technical expert group for the Regional Health System in the Veneto Region.

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026